Luo Da, Wu Hui, Zhou Wenjie, Zhang Jing, Jin Xing, Xu Changwu, Huang Bing, Yang Jian, Jiang Hong, Chen Jing
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Research Institute of Wuhan University, Wuhan, China.
ESC Heart Fail. 2023 Oct;10(5):2914-2926. doi: 10.1002/ehf2.14452. Epub 2023 Jul 16.
Suboptimal perfusion leading to heart failure (HF) often occurs after ST-segment elevation myocardial infarction (STEMI), despite restoration of epicardial coronary flow in primary percutaneous coronary intervention (PPCI) era. We determined the clinical implications of angio-based coronary functional assessment in evaluation of suboptimal perfusion and further outcomes among STEMI patients after successful PPCI.
In this study, STEMI patients in the Chinese STEMI PPCI registry trial (NCT04996901) who achieved post-PPCI thrombolysis in myocardial infarction grade 3 flow were retrospectively screened. Post-procedural quantitative flow ratio (QFR), angio-based microvascular resistance (AMR), and coronary flow velocity (CFV) of the infarct-related artery were calculated. QFR and AMR measure epicardial stenosis severity and microvascular resistance, respectively. QFR+ was defined as QFR < 0.90 while QFR- was QFR ≥ 0.90. AMR+ was defined as AMR ≥ 250 mmHgs/m while AMR- was AMR < 250 mmHgs/m. The primary outcome was 30-day new-onset HF. The Kaplan-Meier curves were used to establish the associations between QFR, AMR, CFV, and HF incidences. The relationship between CFV and combined QFR and AMR indices was further assessed. Independent predictors were determined using Cox regression analysis. The receiver-operating characteristic curve was used to assess discriminant ability to predict HF. A total of 942 patients (mean age was 57.8 ± 11.7 years and 84.6% were men) were enrolled. Among them, 129 patients had new-onset HF episodes. Patients in the QFR-/AMR- group had a low risk of HF compared with those in the QFR+/AMR+ group (10.5% vs. 27.3%, P = 0.027). A higher CFV ≥ 17.4 cm/s was associated with low HF incidences as compared with CFV < 17.4 cm/s (10.3% vs. 16.8%, P = 0.005), whereas isolated QFR or AMR did not reveal any marked differences in HF incidences (P = 0.150 and 0.079, respectively). The highest and lowest medians of CFV were observed in the QFR-/AMR- and QFR+/AMR+ groups, respectively. CFV correlated well with the QFR/AMR ratio (adjusted R = 1, P < 0.001) and post-PPCI CFV was found to be an independent predictor of post-STEMI HF (adjusted hazard ratio: 0.61, 95% confidence interval: 0.41-0.90, P = 0.012). The area under curve estimate of the multivariable regression model was 0.749.
CFV is an integrated coronary physiological assessment approach that incorporates epicardial and microcirculatory contributions. Patients with post-PPCI CFV < 17.4 cm/s were strongly associated with a high risk for post-STEMI HF, even achieving thrombolysis in myocardial infarction grade 3 flow. The immediate angio-based coronary functional assessment is a feasible tool for evaluating suboptimal perfusion and risk stratification.
尽管在直接经皮冠状动脉介入治疗(PPCI)时代已恢复心外膜冠状动脉血流,但ST段抬高型心肌梗死(STEMI)后仍常发生导致心力衰竭(HF)的灌注不足。我们确定了基于血管造影的冠状动脉功能评估在评估STEMI患者PPCI成功后灌注不足及进一步预后中的临床意义。
在本研究中,对中国STEMI PPCI注册试验(NCT04996901)中PPCI术后达到心肌梗死溶栓3级血流的STEMI患者进行回顾性筛查。计算梗死相关动脉的术后定量血流比(QFR)、基于血管造影的微血管阻力(AMR)和冠状动脉血流速度(CFV)。QFR和AMR分别测量心外膜狭窄严重程度和微血管阻力。QFR+定义为QFR < 0.90,而QFR-定义为QFR≥0.90。AMR+定义为AMR≥250 mmHgs/m,而AMR-定义为AMR < 250 mmHgs/m。主要结局为30天新发HF。采用Kaplan-Meier曲线确定QFR、AMR、CFV与HF发生率之间的关联。进一步评估CFV与联合QFR和AMR指数之间的关系。使用Cox回归分析确定独立预测因素。采用受试者工作特征曲线评估预测HF的判别能力。共纳入942例患者(平均年龄为57.8±11.7岁,84.6%为男性)。其中,129例患者发生新发HF事件。与QFR+/AMR+组相比,QFR-/AMR-组患者发生HF的风险较低(10.5%对27.3%,P = 0.027)。与CFV < 17.4 cm/s相比,CFV≥17.4 cm/s与较低的HF发生率相关(10.3%对16.8%,P = 0.005),而单独的QFR或AMR在HF发生率上未显示出任何显著差异(分别为P = 0.150和0.079)。CFV的最高和最低中位数分别在QFR-/AMR-组和QFR+/AMR+组中观察到。CFV与QFR/AMR比值相关性良好(调整后R = 1,P < 0.001),且发现PPCI术后CFV是STEMI后HF的独立预测因素(调整后风险比:0.61,95%置信区间:0.41 - 0.90,P = 0.012)。多变量回归模型的曲线下面积估计值为0.749。
CFV是一种综合的冠状动脉生理评估方法,融合了心外膜和微循环的作用。PPCI术后CFV < 17.4 cm/s的患者与STEMI后HF的高风险密切相关,即使达到心肌梗死溶栓3级血流。即时基于血管造影的冠状动脉功能评估是评估灌注不足和风险分层的可行工具。